Tom Newman And VP Discuss Public Health

Plenary Session

Vinay Prasad, MD MPH

Health, Medicine, Policy, Oncology, Science & Medicine

4.7 • 789 Ratings

🗓️ 22 February 2023

⏱️ 57 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Dr. Tom Newman UCSF Emeritus Professor & Superb teacher discusses VP's recent Public Health Videos. The two don't fully agree, but the discussion is worth your time.

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome back to plenary session. Today I stopped by the office. I stopped by the office at
0:06.5	UCSF and I had a discussion with Dr. Tom Newman. He is Professor Emeritus here at UCSF. He was a
0:13.3	practicing pediatrician. He is an evidence-based medicine expert. He's in clinical epidemiologist.
0:20.1	He's a superb teacher. We have a discussion
0:22.5	about public health, about a little bit about clinical epidemiology. In the discussion, he talks
0:30.0	about a YouTube video of mine that he had watched. He had a bone to pick with me. Something about
0:35.1	it he didn't like, 100%. And it was a good discussion, I think.
0:40.5	Before I play the discussion, since you audio listeners may not have seen the video, I think I'll
0:46.2	give you the audio for the video. So you'll know what we're talking about. This was a provocative
0:51.0	video, I think, but also a truthful video, I think, but you'll hear what we say about it.
0:55.9	It's about public health lying about natural immunity. So today's episode, I'm going to play the audio track of this thing. It's only going to be like 17 minutes.
1:03.7	Then you're going to hear our discussion about it. And hopefully soon you hear Tom Newman again. And we're going to do some stuff together that we've been planning, and I think it'll be a lot of fun.
1:12.0	So on that positive note, this is what you get on plenary session.
1:16.3	You get pretty much whatever I want you to get, because if you don't like it, you can switch the episode.
1:20.1	I'm going to be back with more oncology stuff.
1:23.2	I got to talk about Rukaparib.
1:25.0	I got to talk about Karma 3aparib. I got to talk about Karma 3. Not to say there.
1:29.7	Rukaparib, lousy control arm, inappropriate use of crossover. OS differences null.
1:36.0	Of course, they're going to fault that on crossover, but the equally plausible explanation is it doesn't do that much anyway.
1:42.5	The PFS benefit is scant it's really a terrible
1:45.8	study karma three the control arm severely underperforms they do so so badly that you really have to
1:51.9	wonder what the hell was going on in that study they underperform even their own power calculation
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Vinay Prasad, MD MPH, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Vinay Prasad, MD MPH and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.